In last trading session, Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) saw 0.33 million shares changing hands with its beta currently measuring 3.64. Company’s recent per share price level of $0.39 trading at -$0.01 or -2.70% at ring of the bell on the day assigns it a market valuation of $12.40M. That closing price of RDHL’s stock is at a discount of -741.03% from its 52-week high price of $3.28 and is indicating a premium of 33.33% from its 52-week low price of $0.26. Taking a look at company’s average trading volume volume of 327.01K if we extend that period to 3-months.
Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) trade information
Upright in the red during last session for losing -2.70%, in the last five days RDHL remained trading in the red while hitting it’s week-highest on Monday, 06/10/24 when the stock touched $0.39 price level, adding 13.81% to its value on the day. Redhill Biopharma Ltd. ADR’s shares saw a change of -73.34% in year-to-date performance and have moved -9.89% in past 5-day. Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) showed a performance of -15.39% in past 30-days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
RDHL Dividends
Redhill Biopharma Ltd. ADR is more likely to be releasing its next quarterly report in July and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
